Table 2.

Management practices by provider self-report

HBV Management	All Providers (N=148)
Proportion of patients with CHB vaccinated against HAV (N, (%))
1–25%	12 (8)
26–50%	9 (6)
51–75%	29 (20)
75%	84 (57)
None	1 (1)
Uncertain/ Not Reported	13 (9)
Proportion of patients with CHB screened for HCV (N, (%))
1–25%	8 (5)
26–50%	10 (7)
51–75%	20 (14)
75%	103 (70)
None	2 (1)
Uncertain/ Not Reported	5 (4)
Proportion of patients with CHB screened for HIV (N, (%))
1–25%	16 (11)
26–50%	25 (17)
51–75%	29 (20)
75%	69 (47)
None	2 (1)
Uncertain/ Not Reported	7 (4)
Provider offers HBV treatment in their practice (N, (%))	28 (19)
Self-rated familiarity with AASLD HBV guidelines (N, (%))
Not Familiar	64 (43)
Somewhat/Very Familiar	83 (56)
Not reported	1 (1)
Provide HCC surveillance for patients with CHB (N, (%))	142 (96)
Proportion of patients with CHB screened for HCC (N, (%))
1–25%	9 (6)
26–50%	18 (12)
51–75%	33 (22)
75%	68 (46)
None	1 (1)
Uncertain/Not Reported	19 (13)